Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications hifmech study group plasminogen activator inhibitor 1 675 4g5g genotype influences risk
… was a director in the patient-reported outcomes assessment group at a pharmaceutical company, responsible for developing …
… populations, comparator selection, relevant endpoints, study design, and an economic evidence-generation plan. The …
… 2024 on the New Dossier Format Version 5.0 Share on: May 1, 2024 Image Contributor: Jennifer Alkire, PharmD, Senior … significantly to the knowledge base of the product as study summaries and evidence tables. Include specific types …
Sean D Candrilli Health Economics Respiratory Psychiatry Oncology Gastroenterology Diabetes & Endocrine Disorders Cardiovascular Telecommuter - USA PhD, Pharmaceutical Administration The Ohio State University, Columbus, OH MS, Economics BS, Economics BS, …
… (la/mUC): Results from the realworld US PATRIOT-II study. Grivas P, Barata P, Moon H, Gupta S, Hutson T, … K, Weiner E, Rivero-Ferrer E. Poster Presentation: P1 1:00-2:30 pm, CT April 16, 2024 #AMCP2024 …
… Scientist in the Patient-Centered Outcomes Assessment group with RTI-HS. Dr. Myer is experienced in qualitative and …
… Manager in the Market Access and Outcomes Strategy (MAOS) group at RTI Health Solutions. Ms. Levine has over 15 years …
… esophageal cancer, breast cancer, neurofibromatosis type 1, and glioblastoma multiforme. Ms. Juniper has completed a …
… US HTA Strategy and Early Modeling in the Health Economics Group at RTI-HS. She has more than 12 years of experience in …
… a Senior Research Health Economist in the Health Economics group with RTI-HS. Dr. Fox is experienced in developing …